Hypertension Clinical Trials in Houston

Showing 41-60 of 203 trials

Perinatal Outcomes Following Change in Clinical Criteria in for Treatment of Maternal Hypertension

NCT05881252

The purpose of this study is observe outcomes before and after a change in clinical practice in the threshold for management of severe hypertension in pregnancy and the post-partum period. Outcomes will be observed for 10 months under the current (traditional) clinical blood pressure threshold for acute treatment of hypertension, which is \>= 160 millimeters of mercury (mmHg) systolic blood pressure (SBP). This will be followed by one month of education about rationale for the new SBP threshold of \>= 180 mmHg and change of clinical guidelines. Then, there will be 10 months of observation after adopting the updated clinical threshold for acute antihypertensive treatment (\>= 180 SBP).

Maternal Hypertension

The University of Texas Health Science Center, Houston1,003 participantsStarted May 2023

Houston, Texas, United States

COMPLETEDPhase 2< 1 mile

A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (Core OLE)

NCT04712669

The purpose of this study is to assess the safety and efficacy of Rodatristat Ethyl in pulmonary arterial hypertension (PAH) patients.

Pulmonary Arterial Hypertension

Altavant Sciences GmbH108 participantsStarted Mar 2021

Phoenix, Arizona, United States • La Jolla, California, United States • Los Angeles, California, United States +61 more locations

Perinatal Outcomes Following Change in Clinical Criteria in for Treatment of Maternal Hypertension

A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (Core OLE)

Hypertension Trials in Other Cities

Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension

A Study of the Efficacy and Safety of Frespaciguat (MK-5475) in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007)

Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs

Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension

Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States

A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)

An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension

A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Hypertensive Participants With Uncontrolled Blood Pressure

Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124

Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso

MIRACLE of LIFE Study

Dilapan-S®: A Multicenter US E-registry

CLN-0045: Safety, and Efficacy of OTX-TIC in Participants With Open Angle Glaucoma or Ocular Hypertension

Cardiovascular Risk Screening and Risk Reduction in Women Vets

Improving BP Control in Diverse Populations Using BP MAP

Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL)

A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects

Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension

Other Conditions in Houston